VILITRA-10 Centurion Laboratories: Compound Profile
VILITRA-10 Centurion Laboratories is a phosphodiesterase-5 (PDE-5) inhibitor manufactured for in-vitro research applications. This compound belongs to the same class as other selective PDE-5 inhibitors and represents a valuable research tool for investigators studying cyclic guanosine monophosphate (cGMP) pathways and smooth muscle physiology. Researchers at Stroid UK Shop frequently examine vardenafil’s molecular mechanisms to understand endothelial function and nitric oxide signalling cascades in controlled laboratory environments.
Laboratory Applications
Research scientists investigate VILITRA-10 for its selective inhibition properties against PDE-5 enzymes, which play crucial roles in vascular smooth muscle regulation. Cell culture studies examine how vardenafil modulates cGMP degradation pathways, while cardiovascular research models evaluate endothelial-dependent relaxation mechanisms. The compound demonstrates enhanced selectivity compared to other PDE inhibitors in comparative enzyme assays, making it valuable for researchers studying pharmaceutical mechanisms and receptor binding kinetics. Analytical laboratories also utilise this reference standard for developing detection methods and pharmacokinetic studies across various research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Vardenafil HCl |
| Strength | 10mg per unit |
| Form | Research tablets |
| Manufacturer | Centurion Laboratories |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
Researchers studying metabolic pathways often cross-reference findings with selective androgen receptor modulators and peptide compounds to understand broader physiological mechanisms in comprehensive research programmes.
Research Compliance
VILITRA-10 Centurion Laboratories is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain proper laboratory protocols and documentation when studying this material. All investigations should be conducted by qualified personnel in appropriate research facilities with adequate safety measures and institutional oversight.
